Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646226 · ClinicalTrials.gov registry record · NA
The Arteriovenous Vascular (AV) ACCESS Trial
A NA study of End-Stage Kidney Disease and Hemodialysis Complication, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 7
- Study locations
NCT04646226 is a NA study of End-Stage Kidney Disease and Hemodialysis Complication that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 103 participants, below the 461-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (78% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT04646226, a NA study of End-Stage Kidney Disease and Hemodialysis Complication, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
Conditions Studied
Interventions
- DEVICE AV graft
- PROCEDURE surgical intervention for creation of a fistula
Study Locations (7)
Alabama
- University of Alabama at Birmingham School of Medicine - Birmingham
California
- UCLA - Los Angeles
Maryland
- Johns Hopkins School of Medicine - Baltimore
North Carolina
- Atrium Wake Forest Baptist Medical Center - Winston-Salem
South Carolina
- Prisma Health Upstate - Greenville
Tennessee
- University of Tennessee Medical Center at Knoxville - Knoxville
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04646226
The ClinicalTrials.gov registry entry for NCT04646226 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 461-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (78% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with End-Stage Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which AV graft is the first listed.
NCT04646226 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT04646226 about?
NCT04646226 is a clinical study titled "The Arteriovenous Vascular (AV) ACCESS Trial". This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
What is the current status of trial NCT04646226?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2022-08-18. Estimated completion is 2027-08-31.
What conditions does trial NCT04646226 study?
This clinical trial studies the following conditions: End-Stage Kidney Disease, Hemodialysis Complication.
What interventions are being tested in trial NCT04646226?
The interventions under investigation include: AV graft (DEVICE), surgical intervention for creation of a fistula (PROCEDURE).
Who is sponsoring clinical trial NCT04646226?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04646226 being conducted?
This trial has 7 study locations across Alabama, California, Maryland, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End-Stage Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Incremental Hemodialysis: The TwoPlus Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Symptom Monitoring in Hemodialysis
RECRUITING · NA
-
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
RECRUITING · NA
-
Pain Reduction Using NEurostimulation Study
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.